Bristol-Myers Squibb

Bristol-Myers Squibb Company (BMY) is a global biopharmaceutical leader with a strong portfolio of drugs in oncology, immunology, cardiovascular, and fibrosis, including blockbusters like Eliquis, Opdivo, and Revlimid. The company is actively building its next-generation pipeline through strategic acquisitions and internal R&D to offset upcoming patent expirations. BMY offers an attractive dividend yield and trades at a modest valuation relative to big pharma peers, making it appealing for in...

Threads